Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study

Bejanyan, Nelli ; Zhang, Meijie ; Bo-Subait, Khalid ; Brunstein, Claudio ; Wang, Hailin ; Warlick, Erica D. ; Giralt, Sergio ; Nishihori, Taiga ; Martino, Rodrigo ; Passweg, Jakob ; Dias, Ajoy ; Copelan, Edward ; Hale, Gregory ; Gale, Robert Peter ; Solh, Melhem ; Kharfan-Dabaja, Mohamed A. ; Diaz, Miguel Angel ; Ganguly, Siddhartha ; Gore, Steven ; Verdonck, Leo F. ; Hossain, Nasheed M. ; Kekre, Natasha ; Savani, Bipin ; Byrne, Michael ; Kanakry, Christopher ; Cairo, Mitchell S. ; Ciurea, Stefan ; Schouten, Harry C. ; Bredeson, Christopher ; Munker, Reinhold ; Lazarus, Hillard ; Cahn, Jean-Yves ; van Der Poel, Marjolein ; Rizzieri, David ; Yared, Jean A. ; Freytes, Cesar ; Cerny, Jan ; Aljurf, Mahmoud ; Palmisiano, Neil D. ; Pawarode, Attaphol ; Bacher, Vera Ulrike ; Grunwald, Michael R. ; Nathan, Sunita ; Wirk, Baldeep ; Hildebrandt, Gerhard C. ; Seo, Sachiko ; Olsson, Richard F. ; George, Biju ; de Lima, Marcos ; Hourigan, Christopher S. ; Sandmaier, Brenda M. ; Litzow, Mark ; Kebriaei, Partow ; Saber, Wael ; Weisdorf, Daniel

Transplantation and cellular therapy, 2021-01, Vol.27 (1), p.68.e1-68.e9 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível